Eosinophils in COPD—Current Concepts and Clinical Implications
- 3 April 2020
- journal article
- review article
- Published by Elsevier BV in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (8), 2565-2574
- https://doi.org/10.1016/j.jaip.2020.03.017
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Inhaled corticosteroids in COPD and the risk of serious pneumoniaThorax, 2013
- Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: Relationship to disease severityJournal of Allergy and Clinical Immunology, 2012
- Bronchodilator reversibility, airway eosinophilia and anti‐inflammatory effects of inhaled fluticasone in COPD are not relatedRespirology, 2008
- Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trialEuropean Respiratory Journal, 2007
- Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatmentEuropean Respiratory Journal, 2006
- Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase– and cathepsin-dependent emphysemaJCI Insight, 2000
- Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPDEuropean Respiratory Journal, 2000
- Heterogeneity of human eosinophilsJournal of Allergy and Clinical Immunology, 1989
- The presence of hypodense eosinophils and diminished chemiluminescence response in asthmaJournal of Allergy and Clinical Immunology, 1988